Laboratory of Chromatin Biology, Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Sector 67, S.A.S. Nagar, Mohali, 160 062, Punjab, India,
Mol Cell Biochem. 2014 Mar;388(1-2):95-111. doi: 10.1007/s11010-013-1902-5. Epub 2013 Nov 27.
Diabetic nephropathy (DN) is a microvascular complication associated with diabetes causing slow deterioration of kidneys leading to end-stage renal disease. Timely intervention and diagnosis are crucial in order to ameliorate and halt the progression of DN. Current diagnosis of DN consists of urine assays for detection of microalbuminuria, which have inadequate specificity and sensitivity. Hence, there arises a need to discover stage-specific biomarkers which can aid in the early detection of DN and also in identifying the mechanisms underlying pathogenesis of DN. Therefore the present study was undertaken to identify the differentially expressed proteins in the urine and to examine the pattern of proteomic changes occurring in the rat kidneys during the course of progression of streptozotocin-induced model of DN in rats. Two-dimensional gel electrophoresis coupled to MALDI-TOF mass spectrometry was employed to identify the differentially expressed proteins under diabetic conditions. Among the identified proteins Calgranulin A and Calgranulin B appeared in the urinary proteome at the fourth week of induction of diabetes while we recorded a time-dependent decrease in the expression of major urinary protein (alpha 2u globulin) in the urine as well as kidneys of diabetic rats. Parallel monitoring of targeted proteomic changes in the renal proteome revealed an increase in histone H2B phosphorylation at serine14 along with a gradual decrease in Bcl-2 and MMP-13 expression during the course of progression and development of streptozotocin-induced DN.
糖尿病肾病(DN)是一种与糖尿病相关的微血管并发症,可导致肾脏缓慢恶化,进而导致终末期肾病。及时干预和诊断对于改善和阻止 DN 的进展至关重要。目前,DN 的诊断包括检测微量白蛋白尿的尿液检测,但特异性和敏感性不足。因此,需要发现具有特定阶段的生物标志物,以帮助早期发现 DN 并确定 DN 发病机制的机制。因此,本研究旨在鉴定尿中差异表达的蛋白质,并检查在链脲佐菌素诱导的大鼠 DN 模型进展过程中大鼠肾脏中发生的蛋白质组变化模式。二维凝胶电泳与 MALDI-TOF 质谱联用,以鉴定糖尿病条件下差异表达的蛋白质。在鉴定的蛋白质中,钙粒蛋白 A 和钙粒蛋白 B 在糖尿病诱导的第 4 周出现在尿蛋白质组中,而我们记录到糖尿病大鼠尿液和肾脏中主要尿蛋白(α2u 球蛋白)的表达呈时间依赖性下降。对肾蛋白质组中靶向蛋白质组变化的平行监测显示,组蛋白 H2B 在丝氨酸 14 处的磷酸化增加,同时在链脲佐菌素诱导的 DN 进展和发展过程中 Bcl-2 和 MMP-13 的表达逐渐下降。